Similar Articles
Incorporating patient preferences into osteoarthritis treatment
Yeşim Gökçe Kutsal, Sibel Eyigör, Sevilay Karahan, Rezzan Günaydın, Jale İrdesel, Merih Sarıdoğan, Pınar Borman, Aylin Sarı, Kutay Ordu Gökkaya, Vildan Binay Safer
DOI: 10.46497/ArchRheumatol.2022.8291
Issue: Volume 36 - Issue 4 - December 2021
1758
2204
Biological treatment in resistant adult-onset Still’s disease: A single-center, retrospective cohort study
Seda Çolak, Emre Tekgöz, Maghrur Mammadov, Muhammet Çınar, Sedat Yılmaz
DOI: 10.46497/ArchRheumatol.2022.8669
Issue: Volume 37 - Issue 1 - March 2022
2514
1699
Evaluation of the anti-RANKL monoclonal antibody in rheumatoid arthritis rats
Dawei Lv, Xiaodong Zhao
DOI: 10.46497/ArchRheumatol.2023.9240
Issue: Volume 38 - Issue 1 - March 2023
1773
1582
Unmet needs in psoriatic arthritis, a narrative review
Clementina Lopez-Medina, Umut Kalyoncu, Laure Gossec
DOI: 10.46497/ArchRheumatol.2024.10710
Issue: Volume 39 - Issue 2 - June 2024
3119
1538
New and future perspectives in Behçet's syndrome
Bercemhan Sulu, Gulen Hatemi
DOI: 10.46497/ArchRheumatol.2024.11049
Issue: Volume 39 - Issue 4 - December 2024
1367
1217
Lung involvement is a risk factor for treatment resistance in patients with polymyositis and dermatomyositis
Elif Altunel Kılınç, Bengisu Ece Duman, Süleyman Özbek
DOI: 10.46497/ArchRheumatol.2025.10989
Issue: Volume 40 - Issue 1 - March 2025
103
108